Related Experiment Video
Updated: Feb 11, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
[Association of OSMR gene polymorphisms with dilated cardiomyopathy in a Han Chinese population]
Xiaohui Dai1, Ying Peng, Bin Zhou
1Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China. lrlz1989@163.com.
Insights
Genetic variations in the oncostatin M receptor (OSMR) gene, specifically rs2292016, are linked to the development and prognosis of dilated cardiomyopathy (DCM). The GT genotype increases DCM risk, while the GG genotype indicates a poorer outcome in patients not receiving cardiac resynchronization therapy.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Epidemiology
Background:
- Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
- Genetic factors play a crucial role in DCM pathogenesis.
- The oncostatin M receptor (OSMR) gene is implicated in cardiovascular function.
Purpose of the Study:
- To investigate the association between OSMR gene polymorphisms and DCM in a Han Chinese population.
- To evaluate the impact of specific OSMR single nucleotide polymorphisms (SNPs) on DCM susceptibility and prognosis.
Main Methods:
- Genotyping of two OSMR SNPs (rs2292016 and rs2278329) in 351 DCM patients and 418 healthy controls using TaqMan assay.
- Clinical follow-up of 200 DCM patients for prognosis assessment.
- Statistical analysis to determine associations with DCM development and outcomes.
Main Results:
- The GT genotype of rs2292016 was significantly associated with an increased risk of DCM (OR=1.45, P=0.01).
- In patients not receiving cardiac resynchronization therapy, the GG genotype of rs2292016 independently predicted a poor prognosis (OR=1.69, P=0.017).
- No significant association was observed for rs2278329 with DCM susceptibility or prognosis.
Conclusions:
- Polymorphisms in the OSMR gene, particularly at the rs2292016 locus, are associated with both the development and clinical outcome of dilated cardiomyopathy.
- The rs2292016 SNP may serve as a potential genetic marker for DCM risk and prognosis.
Objective:
To assess the association of polymorphisms of oncostatin M receptor (OSMR) gene with dilated cardiomyopathy (DCM) in a Han Chinese population.
Methods:
For 351 DCM patients and 418 healthy controls, two single nucleotide polymorphisms (SNPs) of the OSMR gene, namely rs2292016 (promoter, -100G/T) and rs2278329 (missense, Asp553Asn), were genotyped with a TaqMan SNP genotyping assay. Two hundred of the patients were also followed up for (49.85 ± 22.52) months.
Results:
For rs2292016, carriers of GT genotype were more likely to develop DCM compared to those with GG and TT genotypes (OR=1.45, 95%CI: 1.09-1.92, P=0.01). For those who did not receive cardiac resynchronization therapy, the GG genotype of rs2292016 was an independent indicator for poor prognosis (OR=1.69, 95%CI: 1.11-2.63, P=0.017). No association was found between genotypes of rs2278329 with the susceptibility or prognosis of DCM.
Conclusion:
Polymorphisms of the OSMR rs2292016 locus are related to the development and outcome of DCM.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
What is Population Genetics?
Cardiomyopathy V: Interprofessional Care
Conservation of Small Populations

